Uncategorized
A Cautious ‘Buy’ – Analyst Lowers Five9 Target Despite Impressive Q1 Results
Needham analyst lowers FIVN’s price forecast to $40 while maintaining Buy rating. Q1 revenue and EPS beat estimates, with strong growth expected. Latest Ratings for FIVN Date Firm Action From To Feb 2022 Needham Maintains Buy Feb 2022 Keybanc Maintains Overweight Feb 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for FIVN View the…
FDA Pushes Potential Approval For Cytokinetics’ Experimental Heart Drug By Three Months
FDA extended the aficamten decision deadline to Dec. 26 after classifying the REMS submission as a major amendment to the NDA review. read more
McDonald’s Stumbles On Weak Traffic, Despite Margin Gains And Analyst Optimism
McDonald’s shares underperformed the S&P 500 despite meeting earnings expectations due to disappointing sales trends. Latest Ratings for MCD Date Firm Action From To Mar 2022 Northcoast Research Downgrades Buy Neutral Jan 2022 Barclays Maintains Overweight Jan 2022 Keybanc Maintains Overweight View More Analyst Ratings for MCD View the Latest Analyst Ratings read more
Deal Dispatch: Chef Boyardee, Crumbl Appear Tasty To Buyers While Bankruptcies Tick Upward
Cookie company Crumbl looks for dough while Forever 21 folds; the deal market was especially active this week. read more
Electronic Arts (EA) Stock Climbs 4% Amid GTA VI Delay
Electronic Arts shares rose 4.3% Friday afternoon. The stock gained following Rockstar Games’ announcement that Grand Theft Auto VI, originally slated for fall 2025. read more
‘We’re Not Guessing The Market, We’re Managing It’: Inside TSPY’s Bold Strategy With CEO Si Katara
TSPY is an actively managed fund that combines SPY exposure with daily options to provide reliable income and risk management in volatile markets. read more
Bitcoin, Ethereum, XRP, Dogecoin Hold Steady As Bulls Eye Further Gains
Cryptocurrency markets are treading water as the market enters a quiet stretch ahead of a key week for macroeconomic data. read more